# Wieland Capital

Wieland Capital is a Single Family Office based in Munich, Germany.

## Overview

- **Organization type:** Single Family Office
- **Headquarters:** Munich, Germany
- **Region:** Europe
- **Address:** Schumannstraße 4, 81679 Munich, Germany
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** wieland-capital.com
- **LinkedIn:** https://www.linkedin.com/company/wieland-capital

## Regulatory record

- **Reports private funds:** No

## About

Robert Wieland established Wieland Capital in 2004 following the sale of ESPE. The firm manages capital generated by that transaction for subsequent generations of the Wieland family. It operates exclusively from Munich and invests its own balance sheet. The office targets established mid-sized companies in the DACH region through buyouts, management buy-ins and succession situations. It also participates in selected growth financings and venture capital rounds. Asset classes include private equity, venture capital, residential real estate in Berlin, Leipzig and Dresden, and forestry holdings. Portfolio companies include Peptido, REMEMBER, HKT-Kabeltechnik, Ceranovis, Lifespin, Schlafender Hase, Noscendo, PhagoMed, i3 Membrane, Plasmion, RoamsysNext, Inductio, Cycuria and Dawn-Bio. Co-investors have included High-Tech Gründerfonds, Earlybird Venture Capital, Vsquared Ventures and Revent. The firm maintains a European geographic focus. Team size remains undisclosed. Robert Wieland serves as founder and managing director. Franck Godet joined in 2007 and Melissa Simon joined in 2023. The office holds membership in the Bundesverband Beteiligungskapital. No additional offices or adjacent philanthropic vehicles appear in public records. Wieland Capital structures investments as direct equity positions alongside founders and management. It offers management buy-in capital and maintains no fixed fund life or external LP commitments. This permanent-capital model distinguishes its holding periods from typical private-equity fund cycles.

## Sectors

- Healthcare Services
- Industrial Tech
- Digital Health
- Luxury
- SpaceTech

## People

- Robert Wieland — Founder and Managing Director
- Franck Godet — Partner and Managing Director
- Melissa Simon — Partner

## Questions

### Who runs investment decisions at Wieland Capital?

Robert Wieland serves as founder and managing director. Franck Godet acts as partner and managing director. Melissa Simon joined as partner in 2023 with a focus on pharma, life sciences and health tech.

### How does Wieland Capital source proprietary deal flow?

The firm targets succession situations and management buy-ins in the DACH region. It maintains direct relationships with founders and management teams of mid-sized companies.

### Does Wieland Capital participate in fund commitments or only direct deals?

The office executes direct equity investments and co-investments. It does not disclose external fund commitments.

### Does Wieland Capital maintain philanthropic structures, and how are they separated?

No philanthropic vehicles are disclosed in public materials. All listed activities relate to the family's direct investment portfolio.

### What is Wieland Capital's known posture on co-investments alongside external GPs?

The firm co-invests with partners including High-Tech Gründerfonds, Earlybird Venture Capital and Vsquared Ventures in healthcare and technology rounds.

## Related profiles

- [Wiegers Capital Partners](https://altss.com/profile/wiegers-capital-partners-wiegers-family-office)
- [Wigan Acquisitions](https://altss.com/profile/wigan-acquisitions)

---

Last updated: 2026-08-10T15:54:10.904Z

Canonical page: https://altss.com/profile/wieland-capital-family-office-wieland-family-office

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology